Skip to main content
. 2022 Mar 10;11(6):947. doi: 10.3390/cells11060947

Figure 3.

Figure 3

The potential clinical application of EV-derived ncRNAs in tumor angiogenesis (A) EV-derived ncRNAs can be detected from patient samples and are potential diagnostic and prognostic biomarkers. (B) A combination of targeting EV-derived ncRNAs and using conventional anti-angiogenic agents can enhance therapeutic efficacy.